These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22306368)

  • 1. A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire.
    Lesseur C; Gilbert-Diamond D; Andrew AS; Ekstrom RM; Li Z; Kelsey KT; Marsit CJ; Karagas MR
    Toxicol Lett; 2012 Apr; 210(1):100-6. PubMed ID: 22306368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk.
    Andrew AS; Mason RA; Kelsey KT; Schned AR; Marsit CJ; Nelson HH; Karagas MR
    Toxicol Lett; 2009 May; 187(1):10-4. PubMed ID: 19429237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
    Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
    Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between Arsenic (+3 Oxidation State) Methyltransferase Genetic Polymorphisms and Methylation Capacity of Inorganic Arsenic].
    Agusa T; Kunito T; Minh Tue N; Thi Mai Lan V; Binh Minh T; Thi Kim Trang P; Fujihara J; Takeshita H; Takahashi S; Hung Viet P; Tanabe S; Iwata H
    Nihon Eiseigaku Zasshi; 2015; 70(3):186-96. PubMed ID: 26411936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer.
    Karagas MR; Andrew AS; Nelson HH; Li Z; Punshon T; Schned A; Marsit CJ; Morris JS; Moore JH; Tyler AL; Gilbert-Diamond D; Guerinot ML; Kelsey KT
    Hum Genet; 2012 Mar; 131(3):453-61. PubMed ID: 21947419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic metabolism efficiency has a causal role in arsenic toxicity: Mendelian randomization and gene-environment interaction.
    Pierce BL; Tong L; Argos M; Gao J; Farzana J; Roy S; Paul-Brutus R; Rahaman R; Rakibuz-Zaman M; Parvez F; Ahmed A; Quasem I; Hore SK; Alam S; Islam T; Harjes J; Sarwar G; Slavkovich V; Gamble MV; Chen Y; Yunus M; Rahman M; Baron JA; Graziano JH; Ahsan H
    Int J Epidemiol; 2013 Dec; 42(6):1862-71. PubMed ID: 24536095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.
    Beebe-Dimmer JL; Iyer PT; Nriagu JO; Keele GR; Mehta S; Meliker JR; Lange EM; Schwartz AG; Zuhlke KA; Schottenfeld D; Cooney KA
    Environ Health; 2012 Jun; 11():43. PubMed ID: 22747749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. As3MT and GST Polymorphisms Influencing Arsenic Metabolism in Human Exposure to Drinking Groundwater.
    González-Martínez F; Sánchez-Rodas D; Varela NM; Sandoval CA; Quiñones LA; Johnson-Restrepo B
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan.
    Hsu LI; Chen WP; Yang TY; Chen YH; Lo WC; Wang YH; Liao YT; Hsueh YM; Chiou HY; Wu MM; Chen CJ
    J Biomed Sci; 2011 Jul; 18(1):51. PubMed ID: 21798077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair dye use and risk of bladder cancer in the New England bladder cancer study.
    Koutros S; Silverman DT; Baris D; Zahm SH; Morton LM; Colt JS; Hein DW; Moore LE; Johnson A; Schwenn M; Cherala S; Schned A; Doll MA; Rothman N; Karagas MR
    Int J Cancer; 2011 Dec; 129(12):2894-904. PubMed ID: 21678399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire.
    Applebaum KM; Karagas MR; Hunter DJ; Catalano PJ; Byler SH; Morris S; Nelson HH
    Environ Health Perspect; 2007 Aug; 115(8):1231-6. PubMed ID: 17687452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of arsenic-induced cardiovascular disease susceptibility with genetic polymorphisms.
    Al-Forkan M; Wali FB; Khaleda L; Alam MJ; Chowdhury RH; Datta A; Rahman MZ; Hosain N; Maruf MF; Chowdhury MAQ; Hasan NKMM; Shawon II; Raqib R
    Sci Rep; 2021 Mar; 11(1):6263. PubMed ID: 33737636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water.
    Andrew AS; Karagas MR; Hamilton JW
    Int J Cancer; 2003 Apr; 104(3):263-8. PubMed ID: 12569548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of GST polymorphisms and arsenic related skin lesions.
    McCarty KM; Ryan L; Houseman EA; Williams PL; Miller DP; Quamruzzaman Q; Rahman M; Mahiuddin G; Smith T; Gonzalez E; Su L; Christiani DC
    Environ Health; 2007 Feb; 6():5. PubMed ID: 17284320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population.
    Törüner GA; Akyerli C; Uçar A; Aki T; Atsu N; Ozen H; Tez M; Cetinkaya M; Ozçelik T
    Arch Toxicol; 2001 Oct; 75(8):459-64. PubMed ID: 11757669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Polymorphisms of Xenobiotic Metabolizing Genes (GSTM1, GSTT1, GSTP1), Gene-Gene Interaction with Association to Lung Cancer Risk in North India; A Case Control Study.
    Ritambhara ; Tiwari S; Vijayaraghavalu S; Kumar M
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2707-2714. PubMed ID: 31554367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain.
    Cantor KP; Villanueva CM; Silverman DT; Figueroa JD; Real FX; Garcia-Closas M; Malats N; Chanock S; Yeager M; Tardon A; Garcia-Closas R; Serra C; Carrato A; Castaño-Vinyals G; Samanic C; Rothman N; Kogevinas M
    Environ Health Perspect; 2010 Nov; 118(11):1545-50. PubMed ID: 20675267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.